Pozen makes appointments to its executive team

American pharma company Pozen (Nasdaq: POZN) has appointed Mark Glickman as chief commercial officer, Eric Trachtenberg as deputy general counsel, and Jennifer Armstrong as executive vice president of human resources and administration.

Mr Glickman brings more than 20 years of experience in pharmaceutical sales and operations, with expertise in a variety of fields including sales turnarounds, global product introductions and organizational expansions. He most recently served as executive vice president of sales and marketing for Auxilium Pharmaceuticals (Nasdaq: AUXL). Prior to that, he served as vice president in the medical device division at Otsuka America Pharmaceutical, a unit of Japan's Otsuka (TYO: 4768), vice president of human resources.

Adrian Adams, chief executive of Pozen, said: “This is an exciting time for Pozen as we work to combine with Tribute and create Aralez Pharmaceuticals, a premier specialty pharmaceutical company with enhanced offerings and a diversified product portfolio that we believe will provide significant benefits for all of our stakeholders. With the enhancements to the leadership team announced today, I’m confident we will execute at an even faster pace as we head into this next phase of growth and success. I look forward to working in close partnership with Mark, Eric and Jennifer as we work together with all our valued employees to build an even stronger company.”